Plenty of cut and paste articles early on. Will be interesting to see if any commentary follows.
In terms of daptomycin, Mylan and their competitors the cat is out of the bag regarding their intentions. POH's name is being thrown around again, hopefully this time as a positive.
http://www.reuters.com/article/phosphagenics-brief-idUSWNBS01VIO20160106
http://www.businesswire.com/news/home/20160106005744/en/Phosphagenics-Initiates-Arbitration-Mylan
http://www.wallstreet-online.de/nachricht/8237715-phosphagenics-initiates-arbitration-against-mylan
http://www.todayonline.com/singapore/phosphagenics-initiates-arbitration-against-mylan
Ann: Phosphagenics Initiates Arbitration Against Mylan, page-7
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.001(25.0%) |
Mkt cap ! $7.923M | |||
| Open | High | Low | Value | Volume |
| 0.2¢ | 0.3¢ | 0.2¢ | $5.442K | 2.674M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 32 | 43236745 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 44431350 | 23 |
View Market Depth
| Last trade - 10.00am 02/10/2024 (20 minute delay) ? |
| AVE (ASX) Chart |